What caused the 6L9.F stock spike today?

The spike in 6L9.F stock was driven by a liquidity surge and concentrated intraday buying, with volume of **3,500** versus average **279**, not by a fresh earnings release. Thin order books amplified the price move.

Is 6L9.F stock a buy after the volume surge?

After the surge, 6L9.F stock is speculative. Meyka AI gives a **B (61.46)** grade with a HOLD suggestion. Traders may consider short-term setups on confirmed follow-through volume; long-term buyers should wait for margin improvement.

What is Meyka AI's forecast for 6L9.F stock?

Meyka AI's forecast model projects a reference target of **€0.080** for 6L9.F stock, implying **220.00%** upside versus **€0.025**. Forecasts are model-based projections and not guarantees.

What key metrics should I watch for 6L9.F stock?

Monitor daily volume, follow-through above **5,000** shares, cash per share (**€0.75**), EPS trend, and any operational guidance or order announcements, as these will drive price and sentiment for 6L9.F stock.

DE Stocks

Volume surge: ViewRay (6L9.F XETRA) €0.025 25 Feb 2026 Closed: liquidity watch

ByDanny Kontos February 26, 2026

A large intraday volume spike drove ViewRay, Inc. (6L9.F) to €0.025 on 25 Feb 2026, marking a 12.54x jump in relative volume as XETRA trading closed. The move puts the healthcare device name in our high-volume movers list and forces a closer look at liquidity, short-term technicals, and valuation. Traders should note the tiny float price action against a market cap of €207,228,256.00 and weigh volatility against fundamentals before acting.